APA
Goy A., Bernstein S. H., Kahl B. S., Djulbegovic B., Robertson M. J., de Vos S., Epner E., Krishnan A., Leonard J. P., Lonial S., Nasta S., O'Connor O. A., Shi H., Boral A. L. & Fisher R. I. (20090519). Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Goy A, Bernstein S H, Kahl B S, Djulbegovic B, Robertson M J, de Vos S, Epner E, Krishnan A, Leonard J P, Lonial S, Nasta S, O'Connor O A, Shi H, Boral A L and Fisher R I. 20090519. Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Goy A., Bernstein S. H., Kahl B. S., Djulbegovic B., Robertson M. J., de Vos S., Epner E., Krishnan A., Leonard J. P., Lonial S., Nasta S., O'Connor O. A., Shi H., Boral A. L. and Fisher R. I. (20090519). Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Goy A, Bernstein S H, Kahl B S, Djulbegovic B, Robertson M J, de Vos S, Epner E, Krishnan A, Leonard J P, Lonial S, Nasta S, O'Connor O A, Shi H, Boral A L and Fisher R I. Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. : Annals of oncology : official journal of the European Society for Medical Oncology. 20090519.